Abstract:Flavin-containing monooxygenase 5 (FMO5) is a phase I enzyme that plays an important role in xenobiotic metabolism. Here, we aimed to characterize diurnal rhythms of Fmo5 expression and activity in mouse liver and to investigate the potential roles of clock genes (Bmal1, Rev-erbα, and E4bp4) in the generation of diurnal rhythms. Fmo5 mRNA and protein showed robust diurnal rhythms, with peak values at zeitgeber time (ZT) 10/14 and trough values at ZT2/22 in mouse liver. Consistently, a diurnal rhythm was observed for in vitro microsomal Baeyer-Villiger oxidation of pentoxifylline (PTX), a specific reaction catalyzed by Fmo5. Pharmacokinetic studies revealed a more extensive Baeyer-Villiger oxidation of PTX at dosing time of ZT14 than at ZT2, consistent with the diurnal pattern of Fmo5 protein. Fmo5 expression was downregulated and its rhythm was blunted in Bmal1 -/- and Rev-erbα -/- mice. Positive regulation of Fmo5 by Bmal1 and Rev-erbα was confirmed in primary mouse hepatocytes and/or Hepa1-6 cells. Furthermore, Fmo5 expression was upregulated and its rhythm was attenuated in E4bp4 -/- mice. Negative regulation of Fmo5 by E4bp4 was validated using primary mouse hepatocytes. Combined luciferase reporter and chromatin immunoprecipitation assays demonstrated that Bmal1 (a known Rev-erbα activator) activated Fmo5 transcription via direct binding to an E-box (-1822/-1816 bp) in the promoter, whereas E4bp4 (a known Rev-erbα target gene) inhibited Fmo5 transcription by binding to two D-boxes (-1726/-1718 and -804/-796 bp). In conclusion, circadian clock genes control diurnal expression of Fmo5 through transcriptional actions on E-box and D-box cis-elements. SIGNIFICANCE STATEMENT: Hepatic Fmo5 displayed diurnal rhythmicities in expression and activity in mice. We uncovered the molecular mechanism by which the rhythmic Fmo5 expression was generated. Fmo5 promoter presents E-box and D-box binding elements for transcriptional actions from circadian clock proteins such as Bmal1, E4bp4, and Dbp. These findings have implications for understanding clock-controlled drug metabolism and for facilitating the practice of chronotherapeutics.

Circadian Clock Component Rev-erb α Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice

Circadian Clock Regulation of Hepatic Lipid Metabolism by Modulation of M6a Mrna Methylation.

Nuclear receptor co-repressor RIP140 regulates diurnal expression of cytochrome P450 2b10 in mouse liver

REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis

Integration of the nuclear receptor REV-ERBα linked with circadian oscillators in the expressions of Alas1, Ppargc1a, and Il6 genes in rat granulosa cells

Rev-erbα Regulates Circadian Rhythms and StAR Expression in Rat Granulosa Cells As Identified by the Agonist GSK4112.

Rev-erbalpha2 mRNA encodes a stable protein with a potential role in circadian clock regulation

CRY1/2 regulate rhythmic CYP2A5 in mouse liver through repression of E4BP4

An Intrinsically Disordered Region Controlling Condensation of a Circadian Clock Component and Rhythmic Transcription in the Liver.

Circadian Clock–Controlled Drug Metabolism: Implications for Chronotherapeutics

CDK9 modulates circadian clock by attenuating REV-ERBα activity

The Molecular Mechanism Regulating Diurnal Rhythm of Flavin-Containing Monooxygenase 5 in Mouse Liver.

EGR1 regulates hepatic clock gene amplitude by activating Per1 transcription

Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice

The Hepatic Circadian Clock Modulates Xenobiotic Metabolism in Mice

The nuclear receptor REV‐ERBα is required for the daily balance of carbohydrate and lipid metabolism

Role of the CLOCK protein in liver detoxification

Recent Advances in Hepatic Metabolic Regulation by the Nuclear Factor Rev-erbɑ

Rev-erbα inhibits proliferation by reducing glycolytic flux and pentose phosphate pathway in human gastric cancer cells

Expression and regulation of human fetal-specific CYP3A7 in mice.

REGγ Regulates Circadian Clock by Modulating BMAL1 Protein Stability